Noah Gregory Shuart
About Noah Gregory Shuart
Noah Gregory Shuart serves as the Director of In Vitro Pharmacology and Drug Discovery at Sonata Therapeutics, where he has worked since 2022. He holds a Ph.D. from the University of Washington and has a strong background in drug discovery, particularly in the field of neuroscience and rare diseases.
Work at Sonata Therapeutics
Noah Gregory Shuart serves as the Director of In Vitro Pharmacology and Drug Discovery at Sonata Therapeutics. He has held this position since 2022, contributing to the company's efforts in developing novel therapeutics. His role involves overseeing drug discovery initiatives and managing in vitro biology efforts. Shuart initiated a drug discovery program specifically targeting infantile epilepsies and successfully recruited a team of Ph.D. scientists to support this initiative. His strategic focus ensures that scientific merit aligns with business needs, facilitating the advancement of therapeutic candidates.
Education and Expertise
Noah Gregory Shuart earned a Bachelor of Science degree from Allegheny College and a Doctor of Philosophy from the University of Washington - School of Medicine. His educational background provides a strong foundation in the life sciences, particularly in pharmacology and neuroscience. Shuart possesses extensive expertise in various areas, including strategic partnerships, biotechnology, therapeutics, and rare diseases. His knowledge encompasses numerous target classes and disease areas, making him a valuable asset in drug discovery and development.
Background
Noah Gregory Shuart has a diverse background in drug discovery and pharmacology. He has advanced three clinical-stage small molecule assets through the clinical development pipeline, all of which successfully completed Phase I studies. His experience includes managing aggressive timelines and ensuring the delivery of key milestones in substantial in vitro biology efforts. Shuart has a proven track record of collaborating with big pharmaceutical companies, biotechnology firms, academic institutions, and rare disease nonprofit foundations.
Achievements
In his career, Noah Gregory Shuart has initiated significant drug discovery programs and advanced multiple therapeutic candidates through clinical development. He has demonstrated skill in preclinical research, target selection, in vitro screening, and target validation. His proficiency extends to lead identification, lead optimization, and medicinal chemistry support. Shuart's work in utilizing biophysical methods and his management and science writing skills have contributed to his success in the field of drug discovery.